News & Articles

Convenient blood test uses novel technology to test for recurrence of tumors by detecting circulating DNA

Findings indicate increased specificity in low-risk populations and potential for monitoring tuberculosis treatment

QIAGEN’s GeneReader NGS System Gains Further Validation in Oncology Research Applications with New Independent Performance Review Data

Public-private partnership aims to standardize and clinically validate blood-based biomarkers

New biomarker test designed to aid diagnosis of patients suspected of having Polycythemia Vera form of blood cancer

Selected for screening of 340,000 recruits in 2017 as part of national TB control strategy

European launch of the new CE marked ipsogen CALR RGQ PCR Kit to improve MPN diagnosis for leukemia patients, in line with latest WHO recommendations and clinical guidelines

PAXgene Blood ccfDNA enhances handling and workflow convenience for liquid biopsy applications in prenatal testing and cancer research

Project that measured pathogens in New York City subways goes global this summer

New follow-up assay helps stratify patients with transforming HPV infections

Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS

Actionable Insights Tumor Panel enables monitoring of cancer biomarkers from plasma samples

Reference data set from Horizon affirms proven accuracy of GeneReader workflow